![](/img/cover-not-exists.png)
Cost-effectiveness of dapagliflozin (Forxiga®) added to metformin compared with sulfonylurea added to metformin in type 2 diabetes in the Nordic countries
Sabale, Ugne, Ekman, Mattias, Granström, Ola, Bergenheim, Klas, McEwan, PhilVolume:
9
Language:
english
Journal:
Primary Care Diabetes
DOI:
10.1016/j.pcd.2014.04.007
Date:
February, 2015
File:
PDF, 975 KB
english, 2015